作者:
Shabir A MadhiFrom the Medical Research Council
Respiratory and Meningeal Pathogens Research Unit and the Department of Science and Technology-National Research Foundation Vaccine Preventable Diseases University of the Witwatersrand (S.A.M. C.L.C.) and Shandukani Research Centre Wits Reproductive Health and HIV Institute (M.S.M.) Johannesburg Setshaba Research Centre Soshanguve (K.A. A.O.) and the Family Centre for Research with Ubuntu Department of Paediatrics and Child Health Stellenbosch University Tygerberg Hospital (M.F.C.) and the Department of Paediatrics and Child Health Red Cross War Memorial Children's Hospital South African Medical Research Council Unit on Child and Adolescent Health University of Cape Town (H.J.Z.) Cape Town - all in South Africa Fundación INFANT (F.P.P.
R.L.) Hospital Militar Central Dr. Cosme Argerich (G.P.M.) and the National Scientific and Technical Research Council (R.L.) Buenos Aires and the Department of Pediatric Pulmonology Hospital del Niño Jesús Tucumán (C.J.L.) - both in Argentina the Departments of pediatrics and Molecular Virology and Microbiology
Baylor College of Medicine Houston (P.A.P. F.M.M.) the University of Auckland
Middlemore Hospital Auckland New Zealand (A.A.T.) the Department of pediatrics
University of Colorado School of Medicine and the Children's Hospital Colorado Center for Global Health Colorado School of Public Health Aurora (E.A.F.S.) the Department of Obstetrics and Gynecology
Duke University Durham NC (G.K.S.) Novavax (S.A.
A.A. J.C. I.C. A.F. J.S.P. V.S. D.N.T. J.W. G.M.G. L.F.F.) Gaithersburg and the Department of International Health International Center for Maternal and Newborn Health (A.H.B.) and the Center for American Indian Health Department of International Health (L.H.) Johns Hopkins Bloomberg School of Public Health Baltimore - all in Maryland the Vaccine Institute (A.C.
P.T.H.) and the Vascular Biology Research Centre Molecular and Clinical Sciences Research Institute (A.K.) St. George's Uni
Background:Respiratory syncytial virus(RSV)is the dominant cause of severe lower respiratory tract infection in infants,with the most severe cases concentrated among younger ***:Healthy pregnant women,at 28 weeks 0 da...
详细信息
Background:Respiratory syncytial virus(RSV)is the dominant cause of severe lower respiratory tract infection in infants,with the most severe cases concentrated among younger ***:Healthy pregnant women,at 28 weeks 0 days through 36 weeks 0 days of gestation,with an expected delivery date near the start of the RSV season,were randomly assigned in an overall ratio of approximately 2:1 to receive a single intramuscular dose of RSV fusion(F)protein nanoparticle vaccine or placebo.
作者:
Leila DorlingThe authors' affiliations are as follows: the Centre for Cancer Genetic Epidemiology
Departments of Public Health and Primary Care (L.D. S. Carvalho J.A. K.A.P. Q.W. M.K.B. J.D. B.D. N. Mavaddat K. Michailidou A.C.A. P.D.P.P. D.F.E.) and Oncology (C.L. P.A.H. C. Baynes D.M.C. L.F. V.R. M. Shah P.D.P.P. A.M.D. D.F.E.) University of Cambridge Cambridge the Centre for Genomic and Experimental Medicine MRC Institute of Genetics and Molecular Medicine (A. Campbell D.J.P.) and the Centre for Cognitive Ageing and Cognitive Epidemiology Department of Psychology (D.J.P.) University of Edinburgh the Cancer Research UK Edinburgh Centre (D.A.C. J.F.) and the Usher Institute of Population Health Sciences and Informatics University of Edinburgh Medical School (A. Campbell J.F.) Edinburgh the Divisions of Informatics Imaging and Data Sciences (E.F.H.) Cancer Sciences (A. Howell) Population Health Health Services Research and Primary Care (A. Lophatananon K. Muir) and Evolution and Genomic Sciences School of Biological Sciences (W.G.N. E.M.V. D.G.E.) University of Manchester the NIHR Manchester Biomedical Research Unit (E.F.H.) and the Nightingale Breast Screening Centre Wythenshawe Hospital (E.F.H. H.I.) Academic Health Science Centre and North West Genomics Laboratory Hub and the Manchester Centre for Genomic Medicine St. Mary's Hospital Manchester University NHS Foundation Trust (W.G.N. E.M.V. D.G.E.) Manchester the School of Cancer and Pharmaceutical Sciences Comprehensive Cancer Centre Guy's Campus King's College London London (E.J.S.) the Institute of Cancer and Genomic Sciences University of Birmingham Birmingham (I.T.) and the Wellcome Trust Centre for Human Genetics and Oxford NIHR Biomedical Research Centre University of Oxford Oxford (I.T.) - all in the United Kingdom the Human Genotyping-CEGEN Unit
Human Cancer Genetic Program (A.G.-N. M.R.A. N.Á. B.H. R.N.-T.) and the Human Genetics Group (V.F. A.O. J.B.) Spanish National Cancer Research
Background:Genetic testing for breast cancer susceptibility is widely used,but for many genes,evidence of an association with breast cancer is weak,underlying risk estimates are imprecise,and reliable subtype-specific...
详细信息
Background:Genetic testing for breast cancer susceptibility is widely used,but for many genes,evidence of an association with breast cancer is weak,underlying risk estimates are imprecise,and reliable subtype-specific risk estimates are ***:We used a panel of 34 putative susceptibility genes to perform sequencing on samples from 60,466 women with breast cancer and 53,461 *** separate analyses for protein-truncating variants and rare missense variants in these genes,we estimated odds ratios for breast cancer overall and tumor *** evaluated missense-variant associations according to domain and classification of pathogenicity.
暂无评论